January 19, 2021

The Niche

Trusted stem cell blog & resources

iPS Academia Japan

1 min read

I’ve been researching the issue of how intellectual property (IP) and patents to induced pluripotent stem (iPS) cell will influence the field. It’s a complicated, worrisome picture in terms of getting this technology to patients to help them. I’m concerned there may be an all out patent war. Even for those who do not go to court or challenge each other’s iPS cell patents, but choose instead to go the licensure route, things are troubling. The organization in the driver’s seat is called iPS …Read More